MUC5AC and asthma: Ac-PF-treated mice showed similar symptoms to asthma, including goblet cell and immune cell infiltration, increased mucin production, and hyperplasia of respiratory epithelial cells, which causes the airway tract to become narrow, leading to increased airway hyperresponsiveness in a methacholine dose-dependent manner.